Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives

Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study.

Investors Business Daily

Google Leads Five S&P 500 Stocks Near Buy Points

Google leads this watchlist of five S&P 500 stocks near buy points as the market rally has investors seeing green.

Investors Business Daily

Eli Lilly Stock Nears Another Record As Drugmaker Enters The Weight-Loss Arena

Eli Lilly stock is Monday's IBD Stock Of The Day. Shares are forming a new flat base after the FDA approved Lilly's new weight-loss drug.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Barchart

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

Investors Business Daily

This Option Trade On Eli Lilly Stock Could Return 27% By Mid-January

This iron condor trade on Eli Lilly stock has the potential to return 27% if the stock price stays between about 510 and 680.

Investors Business Daily

Novo Nordisk Stock Skids — But These Weight-Loss Results Are 'Hard To Ignore'

Novo Nordisk stock slumped Monday despite unveiling promising test results for weight-loss drugs and diabetes development.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Top Funds Can't Get Enough Of Amazon — And This Intelligence Play

As a Santa Claus rally begins, the AI boom continues to fuel gains for Palantir and Amazon as top funds place their bets.

Investors Business Daily

Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review

The stock market rally erased weekly gains as the major indexes ended long win streaks amid rebounding yields. Datadog led earnings winners.

Investors Business Daily

Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug

U.S. regulators signed off on Eli Lilly’s diabetes drug Zepbound, which can also be used to aid weight loss like Wegovy and Ozempic.

Fortune

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

The Guardian - UK

Here's How Lilly Plans To Unseat Novo As The Weight-Loss Drugs Kingpin

The FDA approved a highly anticipated weight-loss drug from Eli Lilly on Wednesday. Eli Lilly stock popped on the approval news.

Investors Business Daily

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday

Eli Lilly was an S&P 500 top performer Monday, while energy plays were among the day's biggest winners and losers.

Investors Business Daily

Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners

Cathie Wood's flagship Ark Innovation ETF ARKK just had its best week ever thanks to Roku, DraftKings, Palantir and other huge winners on big news.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Novo Nordisk isn’t alone: Sales of Wegovy rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

Drugs helping weight-loss like Novo Nordisk's Wegovy and Eli Lilly's Mounjaro drove blockbuster sales for the pharma giants in the third quarter.

Investors Business Daily

Dow Jones Futures Rise, Apple Falls On Holiday Outlook; Jobs Report Due

The market roared higher again Thursday, but the jobs report looms large. Apple warned on holiday sales.

Investors Business Daily

Eli Lilly Smashes Forecasts As Mounjaro Sales Rocket 652%

Eli Lilly stock rose early Thursday after diabetes blockbuster Mounjaro helped the company beat sales expectations.

The Street

Eli Lilly slashes 2023 profit outlook despite weight-loss drug earnings boost

Eli Lilly's Mounjaro, a diabetes drug that is expected to received FDA approval for weight loss treatment, generated more than $1.4 billion in September quarter revenues.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stock Index Futures Climb on Hopes of End to Fed Rate Hikes, Apple Earnings on Tap

December S&P 500 futures (ESZ23) are up +0.50%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.70% this morning as market participants weighed the possible peak of the Federal Reserve’s historic tightening campaign and looked ahead to an earnings report from Apple.

Investors Business Daily

Dow Jones Futures Rise: Market Rally Gains Steam On Fed Chief Powell's 'Decay'; Palantir Jumps

Techs led futures higher, with Palantir and Roku among the big earnings winners. Fed chief Jerome Powell signaled no more rate hikes, fueling Wednesday's strong market rally.

Investors Business Daily

Verve Stock Soars On $250 Million Eli Lilly Deal

Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.

Investors Business Daily

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

The good times keep rolling for Novo Nordisk and its weight-loss drugs. But it's bad news for some medical device stocks.

Barchart

Chart of the Day: Eli Lilly - Big Profits in Big Pharma

The Chart of the Day belongs to the pharmaceutical giant Eli Lilly (LLY) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

Investors Business Daily

Investors Scurry To Buy 14 Soaring Stocks As Market Sells Off

Don't assume that all S&P 500 stocks are struggling. A small group are actually thriving, thank you.

Investors Business Daily

Stock Market Volatile After Powell Speech; These Economic Reports Are A Worry

Powell said he is encouraged by the slowing trend in inflation but would not rule out more rate hikes.

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations